Characteristics of patients in the non-SLE/non-LLD group (n=12) and with lupus-like disease (n=29) and a positive Farr assay (≥6 IU/ml) and/or a positive ELIA dsDNA test (≥19 IU/ml). Bold numbers with titres (IU/ml) correspond with positive test results
| Patient number | Farr (IU/ml) | ELIA dsDNA test (IU/ml) | Sex | Age (years) | Clinic |
|---|---|---|---|---|---|
| adsDNA positive indicates a history of a positive anti-dsDNA test. | |||||
| Non-SLE/non-LLD group | |||||
| 1 | 12 | 95 | F | 34 | Raynaud, myositis, ANA positive. |
| During follow up: pericarditis | |||||
| 2 | 21 | 1 | F | 79 | Chronic obstructive pulmonary disease, drug induced hepatitis, ANA negative |
| 3 | 10 | 3 | F | 48 | Myasthenia gravis, ANA negative |
| 4 | 9 | 12 | F | 52 | Sjögren's syndrome, ANA positive |
| 5 | 6 | 1 | F | 69 | Recurrent urinary tract infections, ANA positive |
| 6 | 6 | 2 | F | 38 | Polymyositis, ANA negative |
| 7 | 6 | 2 | F | 45 | Sjögren's syndrome, ANA positive |
| 8 | 2 | 85 | M | 82 | Vocal cord paresis, myelodysplastic syndrome, ANA negative |
| 9 | 3 | 36 | F | 59 | Reumatoid factor positive, nodular reumatoid arthritis, ANA negative |
| 10 | 1 | 31 | M | 51 | Hepatitis B related liver cirrhosis, ANA negative |
| 11 | 2 | 27 | F | 50 | Recent bacterial endocarditis and aortic valve replacement, ANA negative |
| 12 | 3 | 19 | M | 79 | Complex neurological picture with multisystem atrophy, idiopathic myelopathy. Prostate cancer. ANA negative |
| Lupus-like disease: | |||||
| 13 | 1223 | 292 | F | 52 | Thrombocytopenia, arthralgia, autoimmune hepatitis, adsDNA and ANA positive. |
| 14 | 132 | 33 | F | 27 | Arthritis, adsDNA and ANA positive. |
| 15 | 129 | 82 | F | 33 | Arthritis, Sjögren's syndrome, adsDNA and ANA positive. |
| 16 | 105 | 117 | F | 13 | Serositis, arthralgia, Raynaud, vitiligo, adsDNA and ANA positive. |
| 17 | 36 | 45 | M | 46 | Thrombocytopenia, tendinitis, adsDNA and ANA positive |
| 18 | 19 | 38 | F | 40 | Serositis, adsDNA and ANA positive |
| 19 | 11 | 28 | F | 17 | Arthritis, adsDNA and ANA positive |
| 20 | 10 | 42 | F | 16 | Leuco- and thrombocytopenia, arthralgia, adsDNA and ANA positive. |
| 21 | 9 | 21 | F | 19 | Seronegative rheumatoid arthritis, ANA positive |
| 22 | 7 | 24 | F | 46 | Arthritis, antiphospholipid syndrome, ANA positive |
| 23 | 6 | 24 | F | 34 | CDLE, antiphospholipid syndrome, ANA positive |
| 24 | 137 | 13 | F | 22 | Arthritis, myositis, Raynaud, adsDNA and ANA positive. |
| 25 | 92 | 15 | F | 26 | Arthritis, adsDNA and ANA positive |
| 26 | 76 | 3 | M | 7 | Arthritis, adsDNA and ANA-positive |
| During follow up: mild haemolysis | |||||
| 27 | 53 | 14 | F | 54 | Arthritis, adsDNA and ANA-positive |
| 28 | 46 | 3 | F | 37 | Chronic intermittent isolated microscopic haematuria, arthralgia, adsDNA and ANA-positive |
| 29 | 44 | 15 | F | 39 | Arthritis, antiphospholipid syndrome, adsDNA and ANA positive |
| 30 | 41 | 7 | F | 44 | Malar rash, arthralgia, Sjögren's syndrome, adsDNA and ANA positive |
| 31 | 26 | 7 | F | 56 | Serositis, arthralgia, Raynaud, adsDNA and ANA positive |
| 32 | 23 | 13 | F | 29 | Oral ulcers, arthralgia, adsDNA and ANA positive |
| 33 | 20 | 3 | F | 55 | Chronic discoid lupus, myasthenia gravis, adsDNA and ANA positive |
| 34 | 19 | 2 | F | 46 | Arthritis, adsDNA and ANA positive |
| 35 | 10 | 2 | F | 15 | Autoimmune haemolytic anaemia, adsDNA and ANA positive |
| 36 | 9 | 3 | F | 15 | Arthritis, Raynaud, adsDNA and ANA positive |
| 37 | 6 | 9 | F | 48 | Arthritis, ANA positive |
| 38 | 4 | 91 | F | 53 | Chronic discoid lupus, ANA negative |
| 39 | 4 | 26 | M | 37 | Arthritis, ANA-positive |
| 40 | 3 | 19 | F | 34 | Thrombocytopenia, antiphospholipid syndrome, ANA positive |
| 41 | 3 | 19 | F | 38 | Arthritis, serositis, Raynaud, ANA negative |